Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey - Report - MDSpire
Advertisement
Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey
Impact of Leukaemia on the Quality of Life of Adult Informal Caregivers
Overview
This study investigates the quality of life (QoL) of informal caregivers of individuals with leukaemia. Findings indicate that a proportion of caregivers experience poor QoL, particularly those supporting patients with acute leukaemia.
Background
Leukaemia affects not only patients but also their informal caregivers, who provide essential support during treatment. Understanding the QoL of these caregivers is crucial, as their wellbeing can influence healthcare utilization. The challenges faced by informal caregivers of leukaemia patients have been underexplored.
Data Highlights
Group
Median FROM-16 Score
Percentage Above Critical Threshold
Acute Leukaemia
16
38%
Chronic Leukaemia
8
Not specified
Key Findings
Median FROM-16 score for all respondents was 14.
38% of caregivers scored above the critical threshold of 17.
Caregivers of patients with acute leukaemia had a higher median FROM-16 score (16) compared to those with chronic leukaemia (8).
Increased caregiving hours correlated with lower QoL.
Providing medication was associated with moderate effect sizes for both groups, while personal care showed small to moderate effects.
Clinical Implications
The findings suggest that informal caregivers, particularly those supporting patients with acute leukaemia, experience significant QoL challenges. Healthcare providers should consider integrating support for informal caregivers into leukaemia care strategies to address their unique needs.
Conclusion
The study highlights the substantial burden faced by informal caregivers of leukaemia patients, emphasizing the need for tailored support strategies to improve their quality of life.
Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.
